Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Hitomi Yaguramaki
Effectiveness and Safety of Tocilizumab: Postmarketing Surveillance of 7901 Patients With Rheumatoid Arthritis in Japan
Journal of Rheumatology
Rheumatology
Allergy
Immunology
Related publications
Postmarketing Surveillance of the Safety and Effectiveness of Etanercept in Japan
Journal of Rheumatology
Rheumatology
Allergy
Immunology
Long-Term Safety and Effectiveness of Adalimumab for the Treatment of Japanese Patients With Rheumatoid Arthritis: 3-Year Results From a Postmarketing Surveillance of 552 Patients
Modern Rheumatology
Medicine
Rheumatology
Incidence of Gastrointestinal Perforations in Patients With Rheumatoid Arthritis Treated With Tocilizumab From Clinical Trial, Postmarketing, and Real-World Data Sources
Rheumatology and Therapy
Safety and Effectiveness of Adalimumab in Patients With Rheumatoid Arthritis Over 5 Years of Therapy in a Phase 3b and Subsequent Postmarketing Observational Study
Arthritis Research and Therapy
Rheumatology
Allergy
Immunology
Effectiveness, Safety, and Methotrexate Dose-Tapering Pattern Over Two Years of Treatment With Adalimumab and ≥12 Mg/Week Methotrexate for Early Rheumatoid Arthritis: Results of the HAWK Postmarketing Surveillance Study in Japan
Modern Rheumatology
Medicine
Rheumatology
FRI0248 Incidence of Melanoma in Patients With Rheumatoid Arthritis Treated With Tocilizumab
Tocilizumab in Systemic Juvenile Idiopathic Arthritis in a Real-World Clinical Setting: Results From 1 Year of Postmarketing Surveillance Follow-Up of 417 Patients in Japan
Annals of the Rheumatic Diseases
Immunology
Molecular Biology
Biochemistry
Rheumatology
Allergy
Genetics
Immunotherapy of Tocilizumab for Rheumatoid Arthritis
Journal of Clinical & Cellular Immunology
Body Mass Index and Clinical Response to Tocilizumab in Patients With Rheumatoid Arthritis
Archives of Rheumatology
Rheumatology
